Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | FBRX Forte Biosciences, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| VIKING GLOBAL INVESTORS LP | PEPG PepGen Inc. | 13G/A | 5.03% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | KTWO K2 Capital Acquisition Corp | 13G | 8.8% | Mar 31, 2026 | 6mo |
| Solas Capital Management, LLC | MAIA MAIA Biotechnology, Inc. | 13G | 7.1% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | NVNO enVVeno Medical Corp | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | HELP Helus Pharma Inc. | 13G | 7.2% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | GCTK Glucotrack, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Berkshire Hathaway Inc | DAL Delta Air Lines, Inc. | 13G | 6.1% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | RMBS Rambus Inc | 13G/A | 3.1% | Mar 31, 2026 | 6mo |
| Ikarian Capital, LLC | PTHS Pelthos Therapeutics Inc. | 13G/A | 7.7% | Mar 31, 2026 | 6mo |
| Contour Asset Management LLC | ZETA Zeta Global Holdings Corp. | 13G/A | 2.3% | Mar 31, 2026 | 6mo |
| First Trust Capital Management L.P. | TVA Texas Ventures Acquisition III Corp | 13G/A | 2.87% | Mar 31, 2026 | 6mo |
| Fort Baker Capital Management LP | BCSS Bain Capital GSS Investment Corp. | 13G/A | 8.5% | Mar 31, 2026 | 6mo |
| First Trust Capital Management L.P. | FMAC Future Money Acquisition Corp | 13G | 5.21% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | EFSI Eagle Financial Services Inc | 13G/A | 5.2% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | VICR Vicor Corp | 13G | 5.6% | Mar 31, 2026 | 6mo |
| LOCUST WOOD CAPITAL ADVISERS, LLC | GPGI GPGI, Inc. | 13G/A | 4.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | EE Excelerate Energy, Inc. | 13G/A | 8.2% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | PFS Provident Financial Services Inc | 13G/A | 4.4% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | ANAB Anaptysbio, Inc | 13G | 6.7% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | VNOM Viper Energy, Inc. | 13G/A | 4.7% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | OM Outset Medical, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | DBCA D. Boral Acquisition I Corp. | 13G | 6.88% | Mar 31, 2026 | 6mo |
| Rubric Capital Management LP | NFE New Fortress Energy Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | PRAX Praxis Precision Medicines, Inc. | 13G/A | 0.2% | Mar 31, 2026 | 6mo |
| LAZARD ASSET MANAGEMENT LLC | CAF Morgan Stanley China A Share Fund, Inc. | 13G | 11.5% | Mar 31, 2026 | 6mo |
| Greenhouse Funds LLLP | VYX NCR Voyix Corp | 13G/A | 16.1% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | DNOW DNOW Inc. | 13G/A | 9.1% | Mar 31, 2026 | 6mo |
| HARRIS ASSOCIATES L P | CRBG Corebridge Financial, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | JACS Jackson Acquisition Co II | 13G | 5.11% | Mar 31, 2026 | 6mo |
| Darwin Global Management, Ltd. | INSM INSMED Inc | 13G/A | 7.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | AAON Aaon, Inc. | 13G/A | 9.8% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | VCIC Vine Hill Capital Investment Corp. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Alger Associates, Inc. 13-3017981 | ALAI Alger ETF Trust | 13G/A | 10.8% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | WELL Welltower Inc. | 13G | 5.18% | Mar 31, 2026 | 6mo |
| Lagoda Investment Management, L.P. | VNRX Volitionrx Ltd | 13G/A | 10.7% | Mar 31, 2026 | 6mo |
| Durable Capital Partners LP | CIGI Colliers International Group Inc. | 13G/A | 1.7% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | IRWD Ironwood Pharmaceuticals Inc | 13G/A | 9.22% | Mar 31, 2026 | 6mo |
| Fund 1 Investments, LLC | JMIA Jumia Technologies AG | 13G/A | 9.95% | Mar 31, 2026 | 6mo |
| Venrock Healthcare Capital Partners III, L.P. | CTMX CytomX Therapeutics, Inc. | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| MMCAP International Inc. SPC | ARIS Aris Mining Corp | 13G/A | 3.8% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | IMCR Immunocore Holdings plc | 13G/A | 3.7% | Mar 31, 2026 | 6mo |
| BIOTECHNOLOGY VALUE FUND L P | AVTX Avalo Therapeutics, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | POWI Power Integrations Inc | 13G | 6% | Mar 31, 2026 | 6mo |
| Garner Jennifer Anne | OFRM Once Upon a Farm, PBC | 13G | 7.1% | Mar 31, 2026 | 6mo |
| Paradigm Biocapital Advisors LP | EYPT EyePoint, Inc. | 13G/A | 3.8% | Mar 31, 2026 | 6mo |
| Westchester Capital Management, LLC | OAKU Oak Woods Acquisition Corp | 13G | 9.92% | Mar 31, 2026 | 6mo |
| Bain Capital Life Sciences Fund II, L.P. | XLO Xilio Therapeutics, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | LRN Stride, Inc. | 13G | 5.4% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | MTCH Match Group, Inc. | 13G/A | 5.7% | Mar 31, 2026 | 6mo |